Although Th17-associated cytokines promoted MEK inhibitor resistance and cancer cell invasion in 393P and 344SQ cells, 344SQ tumors were more metastatic compared with 393P tumors after acquiring resistance to combination therapy, suggesting a differential response to anti-PD-L1. This evidence concerns the gene MAP2K7 and cancer.